Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature

被引:16
作者
Rutella, Sergio [1 ,2 ]
Vetrano, Stefania [3 ]
Correale, Carmen [3 ]
Graziani, Cristina [4 ]
Sturm, Andreas [5 ]
Spinelli, Antonino [6 ]
De Cristofaro, Raimondo [7 ]
Repici, Alessandro [3 ]
Malesci, Alberto [3 ]
Danese, Silvio [3 ]
机构
[1] Univ Cattolica Sacro Cuore, Sch Med, Dept Hematol, I-00168 Rome, Italy
[2] IRCCS San Raffaele Pisana, Rome, Italy
[3] IRCCS Gastroenterol, Ist Clin Humanitas, Div Gastroenterol, Milan, Italy
[4] Univ Cattolica Sacro Cuore, Sch Med, Dept Gen Pathol, I-00168 Rome, Italy
[5] Univ Clin Charite, Div Med, Dept Gastroenterol, Berlin, Germany
[6] IRCCS Gastroenterol, Div Surg, Ist Clin Humanitas, Milan, Italy
[7] Univ Cattolica Sacro Cuore, Sch Med, Dept Med & Geriatr, I-00168 Rome, Italy
关键词
angiogenesis; tumour necrosis factor; inflammation; inflammatory bowel disease; ENDOTHELIAL GROWTH-FACTOR; ACTIVATED PLATELETS; ULCERATIVE-COLITIS; CD40; LIGAND; T-CELLS; EXPRESSION; INTERLEUKIN-8; PATHWAY; THROMBOPOIETIN; PATHOGENESIS;
D O I
10.1111/j.1582-4934.2010.01033.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although angiogenesis is viewed as a fundamental component of inflammatory bowel disease (IBD) pathogenesis, we presently lack a thorough knowledge of the cell type(s) involved in its induction and maintenance in the inflamed intestinal mucosa. This study aimed to determine whether platelet (PLT) adhesion to inflamed intestinal endothelial cells of human origin may favour angiogenesis. Unstimulated or thrombin-activated human PLT were overlaid on resting or tumour necrosis factor (TNF)-alpha-treated human intestinal microvascular endothelial cells (HIMEC), in the presence or absence of blocking antibodies to either vascular cell adhesion molecule (VCAM)-1, intercellular adhesion molecule (ICAM)-1, integrin alpha(v)beta(3), tissue factor (TF) or fractalkine (FKN). PLT adhesion to HIMEC was evaluated by fluorescence microscopy, and release of angiogenic factors (VEGF and soluble CD40L) was measured by ELISA. A matrigel tubule formation assay was used to estimate PLT capacity to induce angiogenesis after co-culturing with HIMEC. TNF-alpha up-regulated ICAM-1, alpha(v)beta(3) and FKN expression on HIMEC. When thrombin-activated PLT were co-cultured with unstimulated HIMEC, PLT adhesion increased significantly, and this response was further enhanced by HIMEC activation with TNF-alpha. PLT adhesion to HIMEC was VCAM-1 and TF independent but ICAM-1, FKN and integrin alpha(v)beta(3) dependent. VEGF and sCD40L were undetectable in HIMEC cultures either before or after TNF-alpha stimulation. By contrast, VEGF and sCD40L release significantly increased when resting or activated PLT were co-cultured with TNF-alpha-pre-treated HIMEC. These effects were much more pronounced when PLT were derived from IBD patients. Importantly, thrombin-activated PLT promoted tubule formation in HIMEC, a functional estimate of their angiogenic potential. In conclusion, PLT adhesion to TNF-alpha-pre-treated HIMEC is mediated by ICAM-1, FKN and alpha(v)beta(3), and is associated with VEGF and sCD40L release. These findings suggest that inflamed HIMEC may recruit PLT which, upon release of pro-angiogenic factors, actively contribute to inflammation-induced angiogenesis.
引用
收藏
页码:625 / 634
页数:10
相关论文
共 50 条
[41]   An Insight into the Roles of Dietary Tryptophan and Its Metabolites in Intestinal Inflammation and Inflammatory Bowel Disease [J].
Li, Xiaolan ;
Zhang, Zhi-Hong ;
Zabed, Hossain M. ;
Yun, Junhua ;
Zhang, Guoyan ;
Qi, Xianghui .
MOLECULAR NUTRITION & FOOD RESEARCH, 2021, 65 (05)
[42]   Association of Circulating Vitamin D Concentrations with Intestinal but Not Systemic Inflammation in Inflammatory Bowel Disease [J].
Garg, Mayur ;
Rosella, Ourania ;
Lubel, John S. ;
Gibson, Peter R. .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (12) :2634-2643
[43]   The parallel paradigm between intestinal transplant inflammation and inflammatory bowel disease [J].
Belyayev, Leonid ;
Loh, Katrina ;
Fishbein, Thomas M. ;
Kroemer, Alexander .
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2019, 24 (02) :207-211
[44]   Fecal lactoferrin, a marker of intestinal inflammation in children with inflammatory bowel disease [J].
Borkowska, Anna ;
Liberek, Anna ;
Luczak, Grazyna ;
Jankowska, Agnieszka ;
Plata-Nazar, Katarzyna ;
Korzon, Maria ;
Kaminska, Barbara .
ACTA BIOCHIMICA POLONICA, 2015, 62 (03) :541-545
[45]   Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease [J].
Konikoff, Michael R. ;
Denson, Lee A. .
INFLAMMATORY BOWEL DISEASES, 2006, 12 (06) :524-534
[46]   Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients [J].
Rotonya M. Carr ;
Arpan Patel ;
Hillary Bownik ;
Amanke Oranu ;
Caroline Kerner ;
Amy Praestgaard ;
Kimberly A. Forde ;
K. Rajender Reddy ;
Gary R. Lichtenstein .
Digestive Diseases and Sciences, 2017, 62 :1354-1361
[47]   Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients [J].
Carr, Rotonya M. ;
Patel, Arpan ;
Bownik, Hillary ;
Oranu, Amanke ;
Kerner, Caroline ;
Praestgaard, Amy ;
Forde, Kimberly A. ;
Reddy, K. Rajender ;
Lichtenstein, Gary R. .
DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (05) :1354-1361
[48]   Serum concentration of selected biochemical markers of endothelial dysfunction and inflammation in patients with the varying activity of inflammatory bowel disease [J].
Cibor, Dorota ;
Szczeklik, Katarzyna ;
Koziol, Kamil ;
Pocztar, Halina ;
Mach, Tomasz ;
Owczarek, Danuta .
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2020, 130 (7-8) :598-606
[49]   Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease [J].
Jayawardena, Dulari ;
Anbazhagan, Arivarasu N. ;
Guzman, Grace ;
Dudeja, Pradeep K. ;
Onyuksel, Hayat .
MOLECULAR PHARMACEUTICS, 2017, 14 (11) :3698-3708
[50]   Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation? [J].
Moulton, C. D. ;
Pavlidis, P. ;
Norton, C. ;
Norton, S. ;
Pariante, C. ;
Hayee, B. ;
Powell, N. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 197 (03) :308-318